Exendin-4 reverses high glucose-induced endothelial progenitor cell dysfunction via SDF-1β/CXCR7-AMPK/p38-MAPK/IL-6 axis
- PMID: 32556532
- DOI: 10.1007/s00592-020-01551-3
Exendin-4 reverses high glucose-induced endothelial progenitor cell dysfunction via SDF-1β/CXCR7-AMPK/p38-MAPK/IL-6 axis
Abstract
Aim: Exendin-4, a glucagon-like peptide-1 (GLP-1) analog, has been used for treating diabetes mellitus (DM). However, its effects on improving the dysfunction of high glucose (HG)-induced endothelial progenitor cells (EPCs) remain unclear. The present study explored the effects of Exendin-4 on improving dysfunction of EPCs and the underlying mechanism.
Methods: EPCs were isolated from SD rats and identified by flow cytometry. Next, the EPCs were treated by HG and high or low concentration of Exendin-4, and cell viability, migration and tube formation were, respectively, examined by performing MTT assay, wound-healing assay and tube formation assay. Interleukin-6 (IL-6) secretion was measured by enzyme-linked immunosorbent assay (ELISA). The protein expressions of relative stromal-derived growth factor-1β (SDF-1β), C-X-C chemokine receptor type 7 (CXCR7), AMP-activated protein kinase (AMPK), p38 and expressions of CXCR7 and IL-6 in EPCs were measured by Western blot. The cell behaviors of EPCs treated by HG and Exendin-4 with or without silencing of CXCR7 and IL-6 were detected.
Results: Exendin-4 reversed the inhibitory effects of HG on viability, migration and tube formation of EPCs and on SDF-1β/CXCR7-AMPK pathway in EPCs in a dose-dependent manner. Moreover, Exendin-4 promoted the effects of HG on IL-6 level in EPCs through the promotion of p38-MAPK phosphorylation and reduction of cleaved caspase-3 protein expressions in EPCs. However, silencing of CXCR7 and IL-6 reversed the effects of Exendin-4 on cell behaviors, inactivated SDF-1β/CXCR7-AMPK pathway and increased cleaved caspase-3 expression in EPCs.
Conclusions: Exendin-4 could ameliorate HG-induced EPC dysfunction through regulating the production of IL-6 via SDF-1β/CXCR7-AMPK/p38-MAPK axis.
Keywords: Diabetes mellitus; Endothelial progenitor cell dysfunction; Exendin-4; Interleukin-6; SDF-1β/CXCR7–AMPK/p38-MAPK axis.
References
-
- Pippitt K, Li M, Gurgle HE (2016) Diabetes mellitus: screening and diagnosis. Am Fam Physician 93(2):103–109 - PubMed
-
- Lipska KJ, Krumholz H, Soones T, Lee SJ (2016) Polypharmacy in the aging patient: a review of glycemic control in older adults with type 2 diabetes. JAMA 315(10):1034–1045. https://doi.org/10.1001/jama.2016.0299 - DOI - PubMed - PMC
-
- Hinnen D (2017) Glucagon-like peptide 1 receptor agonists for type 2 diabetes. Diabetes Spectr 30(3):202–210. https://doi.org/10.2337/ds16-0026 - DOI - PubMed - PMC
-
- D'Alessio D (2016) Is GLP-1 a hormone: whether and when? J Diabetes Investig. https://doi.org/10.1111/jdi.12466 - DOI - PubMed - PMC
-
- Cao Y, Gao W, Jusko WJ (2012) Pharmacokinetic/pharmacodynamic modeling of GLP-1 in healthy rats. Pharm Res 29(4):1078–1086. https://doi.org/10.1007/s11095-011-0652-x - DOI - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
